Kratom laws in Louisiana

We follow 1 Louisiana rule on kratom and 7-OH products; 1 is a ban.

Louisiana

BannedDo not ship kratom or any mitragynine / 7-hydroxymitragynine product to Louisiana: both are Schedule I controlled substances.

La. R.S. 40:964, Schedule I(G)(1)-(2) · draft

Exact text

§964. Composition of schedules
Schedules I, II, III, IV, and V shall, unless and until added pursuant to R.S. 40:962,
consist of the following drugs or other substances, by whatever official name, common or
usual name, chemical name, or brand name designated:
SCHEDULE I
...
G. Miscellaneous. Unless specifically excepted or contained within a pharmaceutical
product approved by the United States Food and Drug Administration, or unless listed in
another schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances, including their salts, isomers, or salts of isomers,
whenever the existence of such salts, isomers, or salts of isomers is possible within the
specific chemical designation:
(1) 7-hydroxymitragynine
(2) Mitragynine

Federal

Applies nationwide.

BannedMitragynine pseudoindoxyl ("MP", "pseudo") and the 7-OH derivatives MGM-15/MGM-16 are temporarily Schedule I nationwide; don't sell or ship products containing them anywhere in the US.

21 CFR 1308.11(h)(89)-(91) (DEA temporary scheduling order, 91 FR 54948, Aug. 26, 2026) · draft

Exact text

(89) Methyl (E)-2-((1'S,6'S,7'S)-6'-ethyl-4-methoxy-3-oxo- 9672
3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-2,1'-
indolizine]-7'-yl)-3-methoxyacrylate (commonly known as
mitragynine pseudoindoxyl) including its isomers, esters,
...
(90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8- 9673
...
15; also known as dihydro-7-hydroxymitragynine) including its
...
(91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a- 9674
...
(commonly known as MGM-16; also known as 9-fluoro-dihydro-7-
hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine

BannedConcentrated 7-OH products (more than 1 mg 7-OH per gram/mL, or 7-OH more than 1% of the mitragynine content) are about to become federal Schedule I nationwide (DEA order expected on or after Nov. 13, 2026), and FDA already says 7-OH can't lawfully be sold as a supplement or food; don't sell 7-OH tablets or shots.

DEA notice of intent, 91 FR 65370 (Oct. 14, 2026), proposed 21 CFR 1308.11(h)(96)-(97) · draft

Exact text

The substances [7-hydroxymitragynine] and [mitragynine
pseudoindoxyl] be controlled in schedule I [pursuant to 21 U.S.C.
811(h)] when either substance alone, or their combined amount if both
present, is:
(A) Above a specified threshold concentration, that is, greater
than 1 mg per gram (for solid powders, encapsulated material, or other
solid forms) or greater than 1 mg per milliliter (for liquid
preparations), OR
(B) The mass of mitragynine present divided by the mass of [7-
hydroxymitragynine], or [mitragynine pseudoindoxyl], or the combined
amount of [7-hydroxymitragynine] and [mitragynine pseudoindoxyl] if
both present, is less than 100.
...
The temporary scheduling order will be published in the Federal
Register on or after November 13, 2026.